{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:04:34Z","timestamp":1777565074112,"version":"3.51.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ampullary adenocarcinoma (AMPAC) is a rare and heterogeneous malignancy. Here we performed a comprehensive proteogenomic analysis of 198 samples from Chinese AMPAC patients and duodenum patients. Genomic data illustrate that 4q loss causes fatty acid accumulation and cell proliferation. Proteomic analysis has revealed three distinct clusters (C-FAM, C-AD, C-CC), among which the most aggressive cluster, C-AD, is associated with the poorest prognosis and is characterized by focal adhesion. Immune clustering identifies three immune clusters and reveals that immune cluster M1 (macrophage infiltration cluster) and M3 (DC cell infiltration cluster), which exhibit a higher immune score compared to cluster M2 (CD4<jats:sup>+<\/jats:sup> T-cell infiltration cluster), are associated with a poor prognosis due to the potential secretion of IL-6 by tumor cells and its consequential influence. This study provides a comprehensive proteogenomic analysis for seeking for better understanding and potential treatment of AMPAC.<\/jats:p>","DOI":"10.1038\/s41421-024-00742-4","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T01:01:43Z","timestamp":1736211703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Integrated proteogenomic characterization of ampullary adenocarcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Qiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoshuai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-4280","authenticated-orcid":false,"given":"Jinwen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenmei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rundong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-3464","authenticated-orcid":false,"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"742_CR1","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.3390\/curroncol28050293","volume":"28","author":"A Rizzo","year":"2021","unstructured":"Rizzo, A., Dadduzio, V., Lombardi, L., Ricci, A. D. & Gadaleta-Caldarola, G. Ampullary carcinoma: an overview of a rare entity and discussion of current and future therapeutic challenges. Curr. Oncol. 28, 3393\u20133402 (2021).","journal-title":"Curr. Oncol."},{"key":"742_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal, A. et al. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71\u201396 (2008).","journal-title":"CA Cancer J. Clin."},{"key":"742_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.14694\/EdBook_AM.2014.34.112","volume":"34","author":"DH Ahn","year":"2014","unstructured":"Ahn, D. H. & Bekaii-Saab, T. Ampullary cancer: an overview. Am. Soc. Clin. Oncol. Educ. Book. 34, 112\u2013115 (2014).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"742_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra, J., Schwartz, A. M., Batich, K. & Henson, D. E. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J. Surg. Oncol. 100, 598\u2013605 (2009).","journal-title":"J. Surg. Oncol."},{"key":"742_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/jso.23600","volume":"110","author":"K Okano","year":"2014","unstructured":"Okano, K. et al. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma. J. Surg. Oncol. 110, 156\u2013162 (2014).","journal-title":"J. Surg. Oncol."},{"key":"742_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.6004\/jnccn.2023.0034","volume":"21","author":"EG Chiorean","year":"2023","unstructured":"Chiorean, E. G. et al. Ampullary adenocarcinoma, Version 1.2023, NCCN clinical practice guidelines in oncology. J. Natl Compr. Cancer Netw. 21, 753\u2013782 (2023).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"742_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s43657-022-00089-4","volume":"3","author":"W Ying","year":"2023","unstructured":"Ying, W. Phenomic studies on diseases: potential and challenges. Phenomics 3, 285\u2013299 (2023).","journal-title":"Phenomics"},{"key":"742_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.amjsurg.2017.01.029","volume":"214","author":"MT Chavez","year":"2017","unstructured":"Chavez, M. T. et al. Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma. Am. J. Surg. 214, 856\u2013861 (2017).","journal-title":"Am. J. Surg."},{"key":"742_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.pan.2020.01.009","volume":"20","author":"L Bolm","year":"2020","unstructured":"Bolm, L. et al. Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy\u2014a multicenter cohort study. Pancreatology 20, 433\u2013441 (2020).","journal-title":"Pancreatology"},{"key":"742_CR10","doi-asserted-by":"publisher","unstructured":"Zhao, C. et al. Synergistically augmenting cancer immunotherapy by physical manipulation of pyroptosis induction. Phenomics https:\/\/doi.org\/10.1007\/s43657-023-00140-y (2024).","DOI":"10.1007\/s43657-023-00140-y"},{"key":"742_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","volume":"29","author":"S Yachida","year":"2016","unstructured":"Yachida, S. et al. Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma. Cancer Cell 29, 229\u2013240 (2016).","journal-title":"Cancer Cell"},{"key":"742_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","volume":"14","author":"MC Gingras","year":"2016","unstructured":"Gingras, M. C. et al. Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation. Cell Rep. 14, 907\u2013919 (2016).","journal-title":"Cell Rep."},{"key":"742_CR13","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"JP Brunet","year":"2004","unstructured":"Brunet, J. P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. USA 101, 4164\u20134169 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"742_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/44565","volume":"401","author":"DD Lee","year":"1999","unstructured":"Lee, D. D. & Seung, H. S. Learning the parts of objects by non-negative matrix factorization. Nature 401, 788\u2013791 (1999).","journal-title":"Nature"},{"key":"742_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049.e19 (2019).","journal-title":"Cell"},{"key":"742_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","volume":"35","author":"DG Mun","year":"2019","unstructured":"Mun, D. G. et al. Proteogenomic characterization of human early-onset gastric cancer. Cancer Cell 35, 111\u2013124.e10 (2019).","journal-title":"Cancer Cell"},{"key":"742_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 179, 561\u2013577.e22 (2019).","journal-title":"Cell"},{"key":"742_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13045-022-01384-3","volume":"15","author":"Y Tong","year":"2022","unstructured":"Tong, Y. et al. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. J. Hematol. Oncol. 15, 168 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"742_CR19","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","volume":"174","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 174, 1034\u20131035 (2018).","journal-title":"Cell"},{"key":"742_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4161\/cbt.11.7.14948","volume":"11","author":"JR Bertino","year":"2011","unstructured":"Bertino, J. R., Waud, W. R., Parker, W. B. & Lubin, M. Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies. Cancer Biol. Ther. 11, 627\u2013632 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"742_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aad5214","volume":"351","author":"GV Kryukov","year":"2016","unstructured":"Kryukov, G. V. et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science 351, 1214\u20131218 (2016).","journal-title":"Science"},{"key":"742_CR22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aad5944","volume":"351","author":"KJ Mavrakis","year":"2016","unstructured":"Mavrakis, K. J. et al. Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5. Science 351, 1208\u20131213 (2016).","journal-title":"Science"},{"key":"742_CR23","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","volume":"13","author":"LD Engstrom","year":"2023","unstructured":"Engstrom, L. D. et al. MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted cancer. Cancer Discov. 13, 2412\u20132431 (2023).","journal-title":"Cancer Discov."},{"key":"742_CR24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1158\/2159-8290.CD-23-0669","volume":"13","author":"LD Engstrom","year":"2023","unstructured":"Engstrom, L. D. et al. MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer. Cancer Discov. 13, 2412\u20132431 (2023).","journal-title":"Cancer Discov."},{"key":"742_CR25","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1021\/acs.jmedchem.1c01900","volume":"65","author":"CR Smith","year":"2022","unstructured":"Smith, C. R. et al. Fragment-based discovery of MRTX1719, a synthetic lethal inhibitor of the PRMT5\u2022MTA complex for the treatment of MTAP-deleted cancers. J. Med. Chem. 65, 1749\u20131766 (2022).","journal-title":"J. Med. Chem."},{"key":"742_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/modpathol.2015.57","volume":"28","author":"JF Hechtman","year":"2015","unstructured":"Hechtman, J. F. et al. Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2). Mod. Pathol. 28, 1123\u20131129 (2015).","journal-title":"Mod. Pathol."},{"key":"742_CR27","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1073\/pnas.0805009105","volume":"105","author":"B Xiang","year":"2008","unstructured":"Xiang, B. et al. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc. Natl. Acad. Sci. USA 105, 12463\u201312468 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"742_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10390-0","volume":"22","author":"D Peng","year":"2022","unstructured":"Peng, D. et al. Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non-small-cell lung cancer patients: a prospective observational study. BMC Cancer 22, 1323 (2022).","journal-title":"BMC Cancer"},{"key":"742_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13046-018-0872-6","volume":"37","author":"ZC Nwosu","year":"2018","unstructured":"Nwosu, Z. C. et al. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. J. Exp. Clin. Cancer Res. 37, 211 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"742_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818984","volume":"13","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. Construction of a lactate-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in kidney renal clear cell carcinoma. Front. Immunol. 13, 818984 (2022).","journal-title":"Front. Immunol."},{"key":"742_CR31","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1016\/j.ygeno.2021.08.008","volume":"113","author":"H Jiang","year":"2021","unstructured":"Jiang, H., Chen, H., Wan, P. & Chen, N. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma. Genomics 113, 3556\u20133564 (2021).","journal-title":"Genomics"},{"key":"742_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2193-5","volume":"16","author":"ZW Lai","year":"2016","unstructured":"Lai, Z. W. et al. Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses. BMC Cancer 16, 195 (2016).","journal-title":"BMC Cancer"},{"key":"742_CR33","doi-asserted-by":"publisher","first-page":"76279","DOI":"10.18632\/oncotarget.19348","volume":"8","author":"C Shen","year":"2017","unstructured":"Shen, C. et al. Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway. Oncotarget 8, 76279\u201376289 (2017).","journal-title":"Oncotarget"},{"key":"742_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3892\/br.2016.588","volume":"4","author":"R Zhang","year":"2016","unstructured":"Zhang, R., Zhang, J., Wu, Q., Meng, F. & Liu, C. XB130: a novel adaptor protein in cancer signal transduction. Biomed. Rep. 4, 300\u2013306 (2016).","journal-title":"Biomed. Rep."},{"key":"742_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J. Clin. 67, 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"742_CR36","doi-asserted-by":"publisher","first-page":"D240","DOI":"10.1093\/nar\/gkm772","volume":"36","author":"F Diella","year":"2008","unstructured":"Diella, F., Gould, C. M., Chica, C., Via, A. & Gibson, T. J. Phospho.ELM: a database of phosphorylation sites\u2013update 2008. Nucleic Acids Res. 36, D240\u2013D244 (2008).","journal-title":"Nucleic Acids Res."},{"key":"742_CR37","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/bioinformatics\/btn297","volume":"24","author":"CY Yang","year":"2008","unstructured":"Yang, C. Y. et al. PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database. Bioinformatics 24, i14\u2013i20 (2008).","journal-title":"Bioinformatics"},{"key":"742_CR38","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/pmic.200300772","volume":"4","author":"PV Hornbeck","year":"2004","unstructured":"Hornbeck, P. V., Chabra, I., Kornhauser, J. M., Skrzypek, E. & Zhang, B. PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551\u20131561 (2004).","journal-title":"Proteomics"},{"key":"742_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcm.2008.11.003","volume":"18","author":"T Kume","year":"2008","unstructured":"Kume, T. Foxc2 transcription factor: a newly described regulator of angiogenesis. Trends Cardiovasc. Med. 18, 224\u2013228 (2008).","journal-title":"Trends Cardiovasc. Med."},{"key":"742_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cell.2014.07.020","volume":"158","author":"P Cahan","year":"2014","unstructured":"Cahan, P. et al. CellNet: network biology applied to stem cell engineering. Cell 158, 903\u2013915 (2014).","journal-title":"Cell"},{"key":"742_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/gutjnl-2014-308416","volume":"65","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis. Gut 65, 925\u2013934 (2016).","journal-title":"Gut"},{"key":"742_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"742_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fimmu.2016.00604","volume":"7","author":"Y Luo","year":"2016","unstructured":"Luo, Y. & Zheng, S. G. Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms. Front. Immunol. 7, 604 (2016).","journal-title":"Front. Immunol."},{"key":"742_CR44","doi-asserted-by":"publisher","first-page":"29820","DOI":"10.18632\/oncotarget.25661","volume":"9","author":"N Vainer","year":"2018","unstructured":"Vainer, N., Dehlendorff, C. & Johansen, J. S. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget 9, 29820\u201329841 (2018).","journal-title":"Oncotarget"},{"key":"742_CR45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","volume":"24","author":"M Norelli","year":"2018","unstructured":"Norelli, M. et al. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. 24, 739\u2013748 (2018).","journal-title":"Nat. Med."},{"key":"742_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia, S., Vasseur, S. & Guillaumond, F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 5, e189 (2016).","journal-title":"Oncogenesis"},{"key":"742_CR47","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1080\/10408398.2020.1847030","volume":"62","author":"L Barrea","year":"2022","unstructured":"Barrea, L. et al. Could ketogenic diet \u201cstarve\u201d cancer? Emerging evidence. Crit. Rev. Food Sci. Nutr. 62, 1800\u20131821 (2022).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"742_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3892\/ol.2015.3923","volume":"11","author":"N Jansen","year":"2016","unstructured":"Jansen, N. & Walach, H. The development of tumours under a ketogenic diet in association with the novel tumour marker TKTL1: a case series in general practice. Oncol. Lett. 11, 584\u2013592 (2016).","journal-title":"Oncol. Lett."},{"key":"742_CR49","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1089\/dna.2022.0486","volume":"41","author":"S Khoziainova","year":"2022","unstructured":"Khoziainova, S., Rozenberg, G. & Levy, M. Ketogenic diet and beta-hydroxybutyrate in colorectal cancer. DNA Cell Biol. 41, 1007\u20131011 (2022).","journal-title":"DNA Cell Biol."},{"key":"742_CR50","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.3390\/ijms241310753","volume":"24","author":"NE Cortez","year":"2023","unstructured":"Cortez, N. E. et al. A ketogenic diet in combination with gemcitabine mitigates pancreatic cancer-associated cachexia in male and female KPC mice. Int. J. Mol. Sci. 24, 10753 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"742_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.879205","volume":"12","author":"Y Lan","year":"2022","unstructured":"Lan, Y. et al. Ketogenic diets and hepatocellular carcinoma. Front. Oncol. 12, 879205 (2022).","journal-title":"Front. Oncol."},{"key":"742_CR52","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1074\/mcp.M112.023887","volume":"12","author":"P Saraon","year":"2013","unstructured":"Saraon, P. et al. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Mol. Cell Proteom. 12, 1589\u20131601 (2013).","journal-title":"Mol. Cell Proteom."},{"key":"742_CR53","doi-asserted-by":"publisher","first-page":"iii375","DOI":"10.1093\/neuonc\/noaa222.426","volume":"22","author":"P Batchelder","year":"2020","unstructured":"Batchelder, P. et al. Lgg-48. Prolific growth of braf v600e mutant pilocytic astrocytoma while on ketogenic diet: case report. Neuro Oncol. 22, iii375 (2020).","journal-title":"Neuro Oncol."},{"key":"742_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamasurg.2016.3466","volume":"152","author":"JL Williams","year":"2017","unstructured":"Williams, J. L. et al. Association of histopathologic phenotype of periampullary adenocarcinomas with survival. JAMA Surg. 152, 82\u201388 (2017).","journal-title":"JAMA Surg."},{"key":"742_CR55","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2023.07.001","volume":"30","author":"L Gu","year":"2023","unstructured":"Gu, L. et al. Small molecule targeting of transcription-replication conflict for selective chemotherapy. Cell Chem. Biol. 30, 1235\u20131247.e6 (2023).","journal-title":"Cell Chem. Biol."},{"key":"742_CR56","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.1074\/jbc.M113.520429","volume":"289","author":"A Inoue","year":"2014","unstructured":"Inoue, A. et al. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin. J. Biol. Chem. 289, 7109\u20137120 (2014).","journal-title":"J. Biol. Chem."},{"key":"742_CR57","doi-asserted-by":"publisher","first-page":"16354","DOI":"10.1073\/pnas.1214596109","volume":"109","author":"F Huang","year":"2012","unstructured":"Huang, F. et al. Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc. Natl. Acad. Sci. USA 109, 16354\u201316359 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"742_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119132","volume":"1868","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Cepharanthine, a novel selective ANO1 inhibitor with potential for lung adenocarcinoma therapy. Biochim. Biophys. Acta Mol. Cell Res. 1868, 119132 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"742_CR59","doi-asserted-by":"publisher","first-page":"11585","DOI":"10.18632\/oncotarget.3412","volume":"6","author":"F Liu","year":"2015","unstructured":"Liu, F. et al. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-beta signaling. Oncotarget 6, 11585\u201311599 (2015).","journal-title":"Oncotarget"},{"key":"742_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101414","volume":"20","author":"Z Duan","year":"2022","unstructured":"Duan, Z. et al. Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: a systematic review. Transl. Oncol. 20, 101414 (2022).","journal-title":"Transl. Oncol."},{"key":"742_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos, J. P. et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308, 147\u2013156 (2012).","journal-title":"JAMA"},{"key":"742_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jjco\/28.1.12","volume":"28","author":"S Okada","year":"1998","unstructured":"Okada, S. et al. Elevated serum interleukin-6 levels in patients with pancreatic cancer. Jpn J. Clin. Oncol. 28, 12\u201315 (1998).","journal-title":"Jpn J. Clin. Oncol."},{"key":"742_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu, J. Y. et al. Integrative proteomic characterization of human lung adenocarcinoma. Cell 182, 245\u2013261.e17 (2020).","journal-title":"Cell"},{"key":"742_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"742_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-62703-050-2_1","volume":"929","author":"B Reisfeld","year":"2012","unstructured":"Reisfeld, B. & Mayeno, A. N. What is computational toxicology? Methods Mol. Biol. 929, 3\u20137 (2012).","journal-title":"Methods Mol. Biol."},{"key":"742_CR66","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"742_CR67","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1093\/bioinformatics\/btv178","volume":"31","author":"GJ Etherington","year":"2015","unstructured":"Etherington, G. J., Ramirez-Gonzalez, R. H. & MacLean, D. bio-samtools 2: a package for analysis and visualization of sequence and alignment data with SAMtools in Ruby. Bioinformatics 31, 2565\u20132567 (2015).","journal-title":"Bioinformatics"},{"key":"742_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"742_CR69","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"742_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"742_CR71","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"742_CR72","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/bioinformatics\/btaa895","volume":"37","author":"S Wang","year":"2021","unstructured":"Wang, S., Tao, Z., Wu, T. & Liu, X. S. Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis. Bioinformatics 37, 1590\u20131592 (2021).","journal-title":"Bioinformatics"},{"key":"742_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers, Z. R. et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 9, 34 (2017).","journal-title":"Genome Med."},{"key":"742_CR74","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"742_CR75","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.chroma.2013.05.057","volume":"1301","author":"T Yamada","year":"2013","unstructured":"Yamada, T. et al. Supercritical fluid chromatography\/Orbitrap mass spectrometry based lipidomics platform coupled with automated lipid identification software for accurate lipid profiling. J. Chromatogr. A 1301, 237\u2013242 (2013).","journal-title":"J. Chromatogr. A"},{"key":"742_CR76","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nbt.3825","volume":"35","author":"J Feng","year":"2017","unstructured":"Feng, J. et al. Firmiana: towards a one-stop proteomic cloud platform for data processing and analysis. Nat. Biotechnol. 35, 409\u2013412 (2017).","journal-title":"Nat. Biotechnol."},{"key":"742_CR77","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","volume":"20","author":"DN Perkins","year":"1999","unstructured":"Perkins, D. N., Pappin, D. J., Creasy, D. M. & Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551\u20133567 (1999).","journal-title":"Electrophoresis"},{"key":"742_CR78","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nmeth1113","volume":"4","author":"L Kall","year":"2007","unstructured":"Kall, L., Canterbury, J. D., Weston, J., Noble, W. S. & MacCoss, M. J. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat. Methods 4, 923\u2013925 (2007).","journal-title":"Nat. Methods"},{"key":"742_CR79","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1021\/pr200611n","volume":"10","author":"T Taus","year":"2011","unstructured":"Taus, T. et al. Universal and confident phosphorylation site localization using phosphoRS. J. Proteome Res. 10, 5354\u20135362 (2011).","journal-title":"J. Proteome Res."},{"key":"742_CR80","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1002\/pmic.201200017","volume":"12","author":"W Zhang","year":"2012","unstructured":"Zhang, W. et al. LFQuant: a label-free fast quantitative analysis tool for high-resolution LC-MS\/MS proteomics data. Proteomics 12, 3475\u20133484 (2012).","journal-title":"Proteomics"},{"key":"742_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanhausser","year":"2011","unstructured":"Schwanhausser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337\u2013342 (2011).","journal-title":"Nature"},{"key":"742_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r37","volume":"14","author":"P Casado","year":"2013","unstructured":"Casado, P. et al. Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Genome Biol. 14, R37 (2013).","journal-title":"Genome Biol."},{"key":"742_CR83","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512\u2013D520 (2015).","journal-title":"Nucleic Acids Res."},{"key":"742_CR84","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nmeth.2968","volume":"11","author":"H Horn","year":"2014","unstructured":"Horn, H. et al. KinomeXplorer: an integrated platform for kinome biology studies. Nat. Methods 11, 603\u2013604 (2014).","journal-title":"Nat. Methods"},{"key":"742_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"742_CR86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27, 29\u201334 (1999).","journal-title":"Nucleic Acids Res."},{"key":"742_CR87","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"742_CR88","doi-asserted-by":"publisher","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","volume":"42","author":"D Croft","year":"2014","unstructured":"Croft, D. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 42, D472\u2013D477 (2014).","journal-title":"Nucleic Acids Res."},{"key":"742_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"742_CR90","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"742_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"742_CR92","doi-asserted-by":"crossref","unstructured":"The ENCODE Project Consortium. A user\u2019s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011).","DOI":"10.1371\/journal.pbio.1001046"},{"key":"742_CR93","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1200\/JCO.2016.69.4406","volume":"35","author":"MJ Ellis","year":"2017","unstructured":"Ellis, M. J. et al. Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J. Clin. Oncol. 35, 1061\u20131069 (2017).","journal-title":"J. Clin. Oncol."},{"key":"742_CR94","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","volume":"13","author":"ML Whitfield","year":"2002","unstructured":"Whitfield, M. L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977\u20132000 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"742_CR95","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/bioinformatics\/btx415","volume":"33","author":"DD Wiredja","year":"2017","unstructured":"Wiredja, D. D., Koyuturk, M. & Chance, M. R. The KSEA App: a web-based tool for kinase activity inference from quantitative phosphoproteomics. Bioinformatics 33, 3489\u20133491 (2017).","journal-title":"Bioinformatics"},{"key":"742_CR96","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nbt1146","volume":"23","author":"D Schwartz","year":"2005","unstructured":"Schwartz, D. & Gygi, S. P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 23, 1391\u20131398 (2005).","journal-title":"Nat. Biotechnol."},{"key":"742_CR97","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"742_CR98","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"742_CR99","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91\u2013118 (2003).","journal-title":"Mach. Learn."},{"key":"742_CR100","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","volume":"120","author":"A Seckinger","year":"2012","unstructured":"Seckinger, A. et al. Clinical and prognostic role of annexin A2 in multiple myeloma. Blood 120, 1087\u20131094 (2012).","journal-title":"Blood"},{"key":"742_CR101","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387 (2014).","journal-title":"Nature"},{"key":"742_CR102","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385.e18 (2018).","journal-title":"Cell"},{"key":"742_CR103","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"},{"key":"742_CR104","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. science 339, 1546\u20131558 (2013).","journal-title":"science"},{"key":"742_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00742-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T02:01:59Z","timestamp":1736215319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-024-00742-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1038\/s41421-024-00742-4","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was carried out in compliance with the ethical standards of Helsinki Declaration II and approved by the Institution Review Board of Fudan University Zhongshan Hospital (B2019-200R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2"}}